Law ❯ Legal Representation ❯ Contingency Fees
Lead Plaintiff Investor Counsel Investor Compensation Plaintiff Representation Investor Advocacy Investor Litigation
The lawsuit alleges undisclosed weaknesses in third‑party manufacturing controls that put briquilimab trial readouts at risk of being confounded.